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OBJECTIVE: To systematically review the evidence comparing the chest physiotherapy (CPT) with other
forms of non-pharmacological airway clearance therapy (ACT) in order to determine what is the best
intervention which preserves the pulmonary function (PF) in cystic fibrosis (CF) patients.
METHODS: MEDLINE and CINAHL were used to search for randomized studies limited to human,
published in English language between 1980 and May 2009. Key terms included “cystic fibrosis,” “chest
physiotherapy,” “chest physical therapy,” “postural drainage,” “airway clearance therapy,” and “pulmonary
function”. A list of summary tables was developed to assess collected information for the conclusion.
RESULTS: Eight studies met the selection criteria presenting the results or discussion of pulmonary function
(PF) in ACT management for the CF patients. The review found no significant changes in pulmonary
function compared between chest physiotherapy (CPT) with other airway clearance (ACT) techniques.
There were inconsistent and limited clinical evidence to prove neither CPT nor other ACT techniques were
an effective method preserving the pulmonary function (PF) among cystic fibrosis (CF) patients.
CONCLUSION: This review did not reveal the most effective ACT form in preserving the PF in CF. Further
multi-center, long term, appropriately designed clinical studies are suggested to determine the most effective
form of airway clearance therapy that preserves the pulmonary function (PF) in cystic fibrosis (CF) patients.
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Abstract   
 
OBJECTIVE: To systematically review the evidence comparing the chest 
physiotherapy (CPT) with other forms of non-pharmacological airway clearance 
therapy (ACT) in order to determine what is the best intervention which preserves the 
pulmonary function (PF) in cystic fibrosis (CF) patients.  METHODS:  MEDLINE 
and CINAHL were used to search for randomized studies limited to human, published 
in English language between 1980 and May 2009. Key terms included “cystic 
fibrosis,” “chest physiotherapy,” “chest physical therapy,” “postural drainage,” 
“airway clearance therapy,” and “pulmonary function”. A list of summary tables was 
developed to assess collected information for the conclusion.  RESULTS: Eight 
studies met the selection criteria presenting the results or discussion of pulmonary 
function (PF) in ACT management for the CF patients. The review found no 
significant changes in pulmonary function compared between chest physiotherapy 
(CPT) with other airway clearance (ACT) techniques. There were inconsistent and 
limited clinical evidence to prove neither CPT nor other ACT techniques were an 
effective method preserving the pulmonary function (PF) among cystic fibrosis (CF) 
patients. CONCLUSION: This review did not reveal the most effective ACT form in 
preserving the PF in CF. Further multi-center, long term, appropriately designed 
clinical studies are suggested to determine the most effective form of airway 
clearance therapy that preserves the pulmonary function (PF) in cystic fibrosis (CF) 
patients. KEYWORDS:  cystic fibrosis, pulmonary function, airway clearance 
therapy, chest physiotherapy. 
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THE MOST EFFECTIVE FORM OF AIRWAY CLEARANCE THERAPY TO 
PRESERVE THE PULMONARY FUNCTION IN CYSTIC FIBROSIS PATIENTS  
   
Introduction 
 
Cystic fibrosis (CF) is the life limiting genetic disease associated with viscid secretions 
and gradual deterioration of the pulmonary function (PF) 3. The pulmonary complications 
account for more than 90% of the mortality rate in cystic fibrosis patients 19.   
Therapeutically, both chest physiotherapy (CPT) and other non-pharmacological airway 
clearance therapy (ACT) techniques all are recommended as first-line intervention to remove the 
obstructing secretions and to maintain PF of the patients. Chest physiotherapy (CPT) or 
conventional chest physiotherapy includes postural drainage, chest percussion and vibration 
either performed manually or mechanically.  Non-pharmacological airway clearance therapy 
(ACT) or airway clearance techniques which include active cycle of breathing technique 
(ACBT), autogenic drainage (AD), force expiratory flutter (FEF), force expiration technique 
(FET), Positive Expiratory Pressure (PEP), high frequency chest wall oscillator (HFCWO) or 
oscillation devices (OD), and non-invasive ventilation (NIV). 
Pulmonary function (PF) indexes are used for the assessment of the progress of CF. 
Specifically these indexes are: Force expiratory volume in one second (FEV1), force expiratory 
flow at 25% and 75% of vital capacity (FEF25-75), force vital capacity (FVC), functional residual 
capacity (FRC), and total lung capacity (TLC).  The lower the PF indexes, the worse the 
prognosis. Some studies indicated no correlation between the amount of lung secretions 
produced in CF and improvement in pulmonary function3. 
Chest physiotherapy or conventional CPT has been considered as the gold standard 
therapy for CF patients for more than 40 years3,6, 8,19. However, there have been questions about 
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the rationale and validity of the use of this intervention. There were studies even suggesting that 
CPT may not improve the cystic fibrosis patients’ pulmonary function and may even cause 
bronchoconstriction3. Some others studies promoted CPT as a more superior than ACT 
techniques15, 17.  Whereas others stated ACT techniques were more effective than CPT 7, 11, 16. 
More recently, several self-administered alternatives to CPT have been developed in order to 
provide an effective intervention for ACT competing with CPT. Unfortunately, there are few 
data from valid clinical studies available on the effect of CPT and other forms of ACT on 
pulmonary function3. In addition, these studies were short-term, and the participants did not 
represent large enough population of CF patients. There were mixed results and many 
disagreements in different studies comparing the benefits between different forms of ACT with 
chest physiotherapy6,15,17,19. Therefore, there have been many suggestions for further valid 
studies concerning the role of airway clearance therapy (ACT) forms in managing pulmonary 
complications in CF patients. 
 When being a respiratory therapist, the author used to administer CPT, and assisted in 
the use of other ACT techniques to manage the pulmonary complications in CF patients, and 
wondered whether the CPT or another airway clearance therapy (ACT) technique deserved to be 
the gold standard in enhancing the pulmonary function in CF patients. Therefore, the goal of this 
paper is to review the literature in order to determine the most effective form of ACT that 
preserves the pulmonary function in cystic fibrosis patients.   
Materials and Methods 
 
A comprehensive search of the literature using two computer bibliographic search 
systems: MEDLINE, and CINAHL for randomized trials limited to human subjects, published in 
the English language between 1980 and May 2009 were conducted. Key terms included “cystic 
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fibrosis,” “chest physiotherapy,” “chest physical therapy,” “postural drainage,” “airway 
clearance therapy,” “non-pharmacological airway clearance therapy,” and “pulmonary function.” 
Articles were excluded if they did not have results or discussions of pulmonary function in 
relation with cystic fibrosis, airway clearance therapy, and chest physiotherapy. To facilitate the 
analysis and appraisal, summary tables were developed to organize the validity and central 
outcomes from the studies. 
Results 
A total of fifteen trials found in which eight trials were selected , and the other seven were 
excluded. The selected studies had randomized cross-over trials with presentations of pulmonary 
function results used for the analysis and appraisal of this review. They were organized into three 
major groups according to the types of comparisons and central outcomes relating to the 
hypothesis. The evaluations for these three groups are presented respectively in the following: 
Group one has four trials which compare improvement and changes in PF between CPT and PEP 
(Schans 1991, Braggion 1995; Gaskin 1998; and Mcllwaine 2001) . Group two includes two 
trials which compare CPT to NIV (Holland 2003; and Giles 1996). And group three includes two 
trials which compare effectiveness of CPT and OD in improving the PF (Mark 2004; and Gondor 
1999).   
 To select the trials for review the comparison of pulmonary function changes between 
CPT and positive expiratory pressure (PEP), Placidini 2006  which compares between PEP and 
CPT but was excluded for having no data of pulmonary function 20.  In group one, comparing 
between CPT and PEP, Schans 1991 attempted to determine the effectiveness of preserving 
pulmonary function by using single intervention with one treatment of CPT and PEP 4. It was a 
cross-over randomized trial which involved eight pediatric patients. There was no blinding, and 
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description of randomization. The results showed no changes in FRC and TLC for the treatment 
with CPT, and slight improvement in FRC (from 0.1 to 0.3) and TLC (from 0.2 to 0.3) for the 
treatment with PEP.  With the results of this single treatment, Schans 1991 concluded the PEP 
increased the lung volumes in cystic fibrosis patients. Another trial was Braggion 1995 who had 
a cross-over randomized trial to compare between CPT and PEP. This trial involved sixteen CF 
patients with age ranging from fifteen to twenty-seven years old. The trial had two interventions 
with twice CPT treatments per day to compare with the same treatment frequency of PEP1. 
Baseline pulmonary function was assessed before the trial, and measured thirty minutes after 
each treatment. There was no statement of blinding and how randomization was achieved. 
Braggion 1995 found no significant changes in lung function in both interventions, and 
concluded there were no differences in short-term efficacy of CPT on hospitalized CF patients. 
In the same scope of comparing between CPT and PEP, Gaskin 1998 had a randomized parallel 
design trial.  The trial had sixty six (34 males) CF patients within the age ranging from eleven to 
forty five years old. Gaskin 1998 used the data of hospitalization in two years of these patients to 
compare 18. There were no statements or explanation about treatment frequencies, blinding or 
randomization. There were no follow ups about the four drop-out patients. Gaskin 1998 reported 
no significant changes in FEV1 and FVC in both CPT and PEP interventions. Another trial 
evaluated in this group is of Mcllwaine 2001. The goal of this trial was to compare the results of 
the positive expiratory pressure to CPT. The method claimed randomized design but there were 
no clear descriptions on concealment and randomization. The trial involved thirty-six (26 males) 
CF patients; age ranging from six to seventeen years old. There were two interventions, one for 
PEP treatment and one for CPT treatment. Both interventions were performed twice daily for one 
year. FEV1, FVC, and FEF25-75 were measured every three months for one year. The results 
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showed an annual rate of decline of -2.28 percent for FEV1, no changes for FVC and FEF25-75  for 
the group of having CPT. A slight improvement was indicated in the group of using PEP in all 
PF parameters (FEV1 +6.98%; FVC +6.57%; FEF25-75 +3.30%) 12. Mcllwaine 2001 concluded 
PEP was superior to CPT in maintaining PF in CF patients. 
 The second group includes two trials comparing CPT and non-invasive ventilation (NIV). 
Holland 2003 selected twenty six CF patients with ages ranging from twenty to thirty six years 
old. The trial stated cross-over randomized with single intervention of one treatment with CPT 
and NIV for comparison. No description of how randomization was achieved. The total 
outcomes of this trial showed 1.35 percent increase for FEV1, 2.51 percent increase for FVC, and 
0.53 percent for FEF25-75 in the group given with CPT; and 1.35 percent increase for FEV1, 2.55 
percent increase for FVC, and 0.57 percent increase for FEF25-75 in the group given with NIV 2.  
The results showed no significant changes or differences on pulmonary function. Another trial 
found in the group of comparing CPT to NIV presented with PF results was Giles 1996. This 
trial involved sixteen CF patients with ages between seven to seventeen years old 14 . The trial 
stated cross-over randomized but there was no detailed description how it was done. It used the 
data of one month with treatments of CPT and NIV for comparison, but treatment frequency was 
not mentioned. The results presented with no differences or changes on FEV1, FVC, and FEF25-75 
for both interventions between CPT and NIV 14.   
 The third group in this review has two trials (Marks 2004; and Gondor 1999) found with 
pulmonary function results compared between CPT and OD (Oscillation devices which include 
forced flutter valve/ FEF, and high frequency chest wall oscillation/ HFCWO). The review 
excluded  Stites 2006, Hare 2002,  Steen 1999, Newhouse 1998,  and Desmond 1983 for the 
reason that they had the assumption of no changes or differences on pulmonary function between 
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CPT and OD in cystic fibrosis patients but did not  actually present factual data from the trials to 
conclude. The trial of Homnick 1998 compared CPT to FEF, was also excluded for providing 
inconsistent results. The results reported with thirty-three patients whereas there were only 
twenty two patients involved 16. The trial of Marks 2004, as one of its goals, was to compare the 
effective changes in pulmonary function between CPT and a brand name oscillation device (OD) 
called the percussive tech high frequency which was made by Votran Medical Tech 1; 
Sacramento, California 10.  Marks 2004 did not qualify as a valid randomized control trial as 
claimed. The trial involved a small group of nine pediatric CF patients with age ranging from ten 
to twenty-one years old. Marks 2004 received funding from the manufacturer of the device, had 
only single intervention of two treatments. It failed to describe how patients were randomized 
and treated during the trial. Most parts of the study explained about how the device was used, 
how rules and regulation affected it, and the general meaning of PF studies. The collected PF 
data showed a mean percentage change in PF after single treatments with no significant changes 
on pulmonary function between CPT and the OD. The conclusion favored the application of OD 
over CPT in CF patients. However, Marks 2004 went on to call for long-term studies of the 
effects on pulmonary function. Gondor 1999 attempted to compare the short-term effects of CPT 
and the FEF, on pulmonary function in patients with cystic fibrosis 11. The trial had no clear 
description of design, explanation of randomization, or method of analytical method. It involved 
a group of twenty CF patients with age ranging from five to twenty-one years old. The presented 
PF results in both groups showed no improvement or significant difference on FVC or FEV1. 
Gondor 1999 admitted having received funding from the manufacturer of the device to conduct 
the study. 
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Besides the group above mentioned, there was only one trial (Desmond 1983) found to compare 
CPT with no chest physiotherapy 13. But this trial was excluded from the review for the reason 
that there was no description of how the two interventions were conducted, or the demographic 
characteristics of involved patients.  No explanation of randomization, treatment frequency. 
Discussion 
Throughout the review of the trials, the results and comparisons of pulmonary function indexes 
were identified and appraised. The main purpose of this literature review was to determine the 
most effective form of ACT in preserving the pulmonary function in the CF patients. As it was 
expected that either CPT would have been superior to any other form of the ACT techniques or 
vice versa. There was no single study focused mainly on a form of ACT with the ability for 
pulmonary function preservation in CF patients. Among the studies evaluated, most 
investigations and results related to the amounts of sputum expectorated, the preference of a 
certain ACT device due to its cost or convenience but not really the clinical benefit of preserving 
the PF. Eight trials were examined to address the hypothesis but only small sections addressed 
pulmonary function. Four trials compared CPT to PEP, and showed no significant improvement 
or changes in FRC and TLC. Two trials compared CPT to NIV, and indicated no significant 
differences or changes on FEV1, FVC, and FEF25-75.  Two trials compared between CPT and OD, 
HFCWO and FEF, also showed no significant differences or changes in FEV1 and FVC. 
Essentially the collected results to determine the most effective ACT form were all over the 
board and inconclusive. In addition, these trials shared the difficulty of analyzing the data from 
collected trials due to the mixed and inconsistent results on PF improvement.  Even the trials 
conducted in favor of the manufacturers of devices had to conclude with a call for further 
intensive and reliable studies.  
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The seven excluded trials were Placidini 2006; Stites 2006; Hare 2002; Homnick 1998; 
Newhouse 1998; Steen 1991; and Desmond 1983 5,6,8,9,13,16,20.  These trials did seem to realize the 
importance of pulmonary function in CF patients but did not directly address their objectives. At 
times they seemed intent to use the PF results to make points in promoting the role of CPT or 
other forms of ACT such as FEF or OD using results that were not highly valid and reproducible. 
For the completeness and applicability, all the trials had small participants (from five to 
forty CF patients). All of them were short-term with single interventions of less than four 
treatments to compare. There was only one  long trial (Mcllwaine 2001)involved with 36 
pediatric CF patients, and lasted one year with one intervention of two treatments in one day a 
week. None of these study designs were true randomized control trials. All of them had cross-
over designs, and had difficulty to conceal the treatment forms from the participants and the 
administrators. There were ethical concerns in using a placebo form in replace of the CPT in CF 
patients to conduct a valid randomization since chest physiotherapy is firstly prescribed to 
manage the pulmonary complications as soon as a patient is clinically diagnosed with cystic 
fibrosis. Besides the limited scale and short-term process, the factors of potential biases were 
also obvious in most of the reviewed trials, at least three out of eight reviewed trials declared 
receiving funding from the manufacturers of devices to conduct the trials. The analyzed data 
between trials were inconsistent, mixed and unreproducible due to the low validity of the study 
designs and the unclear analytical methods. Consequently, their results did not produce 
significant data in relative to FEV1, FEF25-75, FRC, FVC and TLC to prove which ACT form had 
the most effect in preserving PF among CF patients.  
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Conclusion 
 This review did not reveal the most effective ACT form in preserving the PF in CF 
patients. More alarmingly, the collected results indicated neither CPT nor any other non-
pharmacological ACT techniques effective for that clinical goal. There have been few studies 
attempting to compare the effectiveness between CPT and other ACT techniques in term of 
general clinical benefits. Even fewer limited studies were found to evaluate the effectiveness of 
the ACT techniques on PF among CF patients. And the produced PF data from these limited 
trials were mixed, unreproducible and inconsistent in determining which ACT form was the most 
effective method. Still, CPT and other ACT techniques have been regarded as the effective 
intervention in managing the pulmonary complications in CF patients.  Pulmonary function 
indexes are the criteria needed to evaluate the severity of the CF process 7. Should it be important 
to sort out an effective intervention to improve the PF in CF patients, firstly the determination for 
an effective ACT form is deemed necessary. If one is not found, then it may prompt other 
medical and scientific specialties such as bio-medicine, bio-engineering, genetics, pulmonology, 
or endocrinology to develop their research for improving the PF in CF patients. Therefore this 
paper strongly calls for large-scale, long-term, and valid randomized clinical trials to investigate 
whether CPT and other non-pharmacological ACT forms are effective in preserving the PF in CF 
patients, and if they are, which one is most effective.  
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SUMMARY TABLES OF CHARACTERISTICS OF REVIEWED STUDIES 
 
I. Trials comparing CPT to PEP: 
 
1.  Braggion 1995 
Participants 16 CF patients. Mean age: 20.3 (4) years 
Interventions Cross-over trial. PEP 
Comparisons CPT 
Outcomes No difference or changes between FEV1, FVC, FEF 25-75 
Biases Subjective assessment. No concealment. Single interventions 
2. Schans 1996 
Participants 8 CF patients. Mean age: 16 (3) years 
Interventions Cross-over trial. PEP. Single intervention of one treatment 
Comparisons One treatment of CPT 
Outcomes No difference or changes between TLC, FRC.  
Biases No blinding. No randomization or control  
3. Gaskin 1998 
Participants 66 (34 males) CF patients. Ages: 11-45 years 
Interventions Parallel, randomized. No mention of treatment frequency 
Comparisons CPT daily (No mention of treatment frequency) 
Outcomes FEV1, FVC decreased non-significantly in both interventions 
Biases No details for randomization. No blinding.  
4. Mcllwaine 2001 
Participants 40 CF patients (24 males) Age range: 7-17 years. 
 Patients within one month of hospitalization for pulmonary exacerbation. 
Interventions Randomized, parallel design. Two treatments with FEF daily for 1 year.  
PF measured every 3 months. 
Comparisons Two treatments with PEP 
Outcomes No significant difference or changes between RV, FEV1, FVC, FEF 25-75  
Biases Unclear randomization. No report of drop-outs. Inconsistent final reports. 
 
II.  Trials comparing CPT to NIV: 
1.   Holland 2003 
Participants 26 CF patients. Mean age 27.04 (6.42) years. 
Interventions Cross-over, randomized trial. ACBT, NIV 
Comparisons CPT 
Outcomes No difference or changes between FEV1, FVC, FEF 25-75 
Biases No details for randomization. Single interventions.  
2. Giles 1996 
Participants 16 CF patients. Mean age 13 (4) years. 
Interventions Cross-over randomized. NIV 
Comparisons CPT`. Treatment frequency was not specific. 
Outcomes No difference or changes between FEV1, FVC, FEF 25-75 
Biases No details for randomization, or blinding 
Biases No randomization. Single interventions. Funded by  Scandipharm  
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III.    Trials comparing CPT to OD: 
1. Marks 2004 
Participants 10 CF patients. Ages: 10 -21 years old 
Interventions Cross-over randomized design. Single intervention of 2 treatments on 2 
different days, one week apart. OD 
Comparisons CPT with same intervention 
Outcomes No significant difference or changes on FEV1, FVC, FEF25-75 
Biases No randomization. No blinding. Funded by Voltran Med. Tech. 
2.  Gondor 1999 
Participants 20 CF patients (11 males). Ages: 5-21 years 
Interventions Parallel design. 2-week interventions.  
Treatment frequency not mentioned 11 patients given FEF. 
Comparisons 8 patients given CPT` 
Outcomes No difference or changes between FEV1, FVC. 
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